Icatibant spares invasive airway maneuver for angioedema
from Medscape (free login required)
Subcutaneous icatibant (Firazyr, Shire) in the emergency department can eliminate the need for invasive airway management in patients with life-threatening angioedema due to cardiac medications, according to a new study. In all seven patients who received the drug, angioedema visibly decreased within an hour of administration, reported lead investigator Mark DeBard, M.D., from the Ohio State University Wexler Medical Center in Columbus.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063